Wells Fargo & Company MN Has $49.81 Million Position in CorVel Co. (NASDAQ:CRVL)

Wells Fargo & Company MN boosted its position in CorVel Co. (NASDAQ:CRVL - Free Report) by 169.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 447,724 shares of the business services provider's stock after buying an additional 281,471 shares during the quarter. Wells Fargo & Company MN owned approximately 0.88% of CorVel worth $49,814,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of CRVL. Fifth Third Bancorp increased its position in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock worth $36,000 after purchasing an additional 101 shares during the last quarter. Jones Financial Companies Lllp acquired a new position in CorVel during the fourth quarter worth $37,000. US Bancorp DE raised its position in CorVel by 225.4% during the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider's stock worth $43,000 after acquiring an additional 266 shares in the last quarter. GAMMA Investing LLC lifted its stake in CorVel by 175.2% in the fourth quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock valued at $48,000 after acquiring an additional 275 shares during the last quarter. Finally, CIBC Private Wealth Group LLC grew its position in shares of CorVel by 300.0% in the 4th quarter. CIBC Private Wealth Group LLC now owns 480 shares of the business services provider's stock valued at $53,000 after acquiring an additional 360 shares during the period. Institutional investors and hedge funds own 51.36% of the company's stock.

Remove Ads

CorVel Trading Up 1.9 %

NASDAQ:CRVL traded up $2.18 on Tuesday, hitting $118.56. The company's stock had a trading volume of 20,640 shares, compared to its average volume of 113,200. CorVel Co. has a one year low of $76.20 and a one year high of $128.61. The stock has a fifty day moving average of $111.36 and a two-hundred day moving average of $115.16. The firm has a market capitalization of $6.09 billion, a P/E ratio of 69.74 and a beta of 0.94.

CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Insiders Place Their Bets

In related news, Director Steven J. Hamerslag sold 10,000 shares of CorVel stock in a transaction that occurred on Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the transaction, the director now directly owns 314,000 shares of the company's stock, valued at $38,772,720. This trade represents a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Brandon O'brien sold 1,523 shares of the business's stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total transaction of $182,089.88. Following the transaction, the chief financial officer now owns 17,142 shares of the company's stock, valued at approximately $2,049,497.52. This represents a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,723 shares of company stock worth $5,757,140 over the last three months. Insiders own 47.57% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com raised shares of CorVel from a "hold" rating to a "buy" rating in a report on Tuesday, April 8th.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.